• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Tulobuterol: a full beta-adrenoceptor agonist or a partial beta-agonist with membrane stabilizing activity?

作者信息

Gonzalez-Sicilia L, Perez-Ojeda E, Laorden M L, Brugger A J, Hernandez J

机构信息

Department of General Pathology, Faculty of Medicine, Murcia, Spain.

出版信息

Gen Pharmacol. 1988;19(1):103-6. doi: 10.1016/0306-3623(88)90013-4.

DOI:10.1016/0306-3623(88)90013-4
PMID:2894330
Abstract
  1. The effects of tulobuterol on the atrial rate was compared with those of isoproterenol, pindolol and propranolol in spontaneously beating isolated right atria of the rat. 2. Isoproterenol markedly increased atrial rate. To the contrary, propranolol, pindolol and tulobuterol decreased atrial frequency. The chronotropic effect of tulobuterol was similar to that of pindolol but lower than that of propranolol. 3. Interactions between tulobuterol and isoproterenol showed that tulobuterol potentiated the chronotropic effect of low concentrations of isoproterenol but reduced the positive chronotropic response to higher concentrations of isoproterenol. 4. These results suggest that tulobuterol is a partial agonist on atrial beta-receptor but also seems to have another action (possibly a membrane stabilizing activity) which reduced the originally induced effect on beta-receptors as a non-competitive antagonist.
摘要

相似文献

1
Tulobuterol: a full beta-adrenoceptor agonist or a partial beta-agonist with membrane stabilizing activity?
Gen Pharmacol. 1988;19(1):103-6. doi: 10.1016/0306-3623(88)90013-4.
2
Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.环丙洛尔、扎莫特罗和吲哚洛尔对β-1肾上腺素能受体激动剂及拮抗剂效能和选择性的比较分析
J Pharmacol Exp Ther. 1987 Sep;242(3):1025-34.
3
The beta-agonist drug tulobuterol decreases cardiac automaticity in the rat: comparison with isoproterenol.
Gen Pharmacol. 1985;16(1):65-7. doi: 10.1016/0306-3623(85)90272-1.
4
Intrinsic sympathomimetic activity of (-)-pindolol mediated through a (-)-propranolol-resistant site of the beta1-adrenoceptor in human atrium and recombinant receptors.(-)-吲哚洛尔的内在拟交感活性通过人心房和重组受体中β1-肾上腺素能受体的(-)-普萘洛尔耐药位点介导。
Naunyn Schmiedebergs Arch Pharmacol. 2003 Dec;368(6):496-503. doi: 10.1007/s00210-003-0835-z. Epub 2003 Nov 8.
5
Electrophysiological effects mediated by the stimulation of cardiac beta 2-adrenoceptors with tulobuterol.妥洛特罗刺激心脏β2-肾上腺素能受体介导的电生理效应。
Cardiovasc Drugs Ther. 1987;1(1):101-7. doi: 10.1007/BF02125839.
6
The antagonist and partial beta agonist properties of celiprolol in isolated rat cardiac tissue.塞利洛尔在离体大鼠心脏组织中的拮抗作用和部分β激动剂特性。
Res Commun Chem Pathol Pharmacol. 1986 Feb;51(2):147-61.
7
Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart.大鼠心脏左右心房中β1和β2肾上腺素能受体结合及功能反应
Naunyn Schmiedebergs Arch Pharmacol. 1985 Sep;330(3):193-202. doi: 10.1007/BF00572434.
8
Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.对具有部分激动活性的β肾上腺素能受体拮抗剂扎莫特罗在豚鼠心脏中的心脏作用进行药理学分析:腺苷酸环化酶系统参与其心脏兴奋作用的证据。
J Pharmacol Exp Ther. 1987 Sep;242(3):1077-85.
9
Different mechanisms of positive chronotropic actions of isoprenaline and noradrenaline on isolated guinea pig right atria revealed by pretreatment with rilmakalim.利马卡林预处理揭示异丙肾上腺素和去甲肾上腺素对豚鼠离体右心房正性变时作用的不同机制。
Pol J Pharmacol. 2000 Sep-Oct;52(5):383-8.
10
Do both adrenaline and noradrenaline stimulate cardiac alpha-adrenoceptors to induce positive inotropy of rat atria?肾上腺素和去甲肾上腺素都会刺激心脏α-肾上腺素能受体以诱导大鼠心房产生正性肌力作用吗?
Br J Pharmacol. 1989 Oct;98(2):597-611. doi: 10.1111/j.1476-5381.1989.tb12634.x.